Which has the lower trailing P/E, INCY or UTHR?

INCY has the lower trailing P/E: INCY trades at 15.36 and UTHR at 19.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, INCY or UTHR?

Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus UTHR at 16.05%.

Is INCY or UTHR more profitable?

UTHR runs the higher net margin — INCY at 27.71% versus UTHR at 40.61%.

How have INCY and UTHR total returns compared?

Over the past 10 years, INCY delivered 2.96% and UTHR delivered 15.25% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Incyte Corporation and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 5, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$24.28B

$119.80HealthcareDelayed quote: Aug 5, 2026, 4:00 PM EDT

UTHR

United Therapeutics Corporation

$22.03B

$519.01HealthcareDelayed quote: Aug 5, 2026, 4:00 PM EDT

Total return — INCY vs UTHR

growth of $100 · dividends reinvested · last 27y

INCY +957.3%UTHR +8411.7%UTHR compounded faster

Log scale — wide-divergence pair

INCY UTHR

INCY vs UTHR: by the numbers

•INCY is the larger company ($24.28B vs $22.03B market cap).
•INCY trades at the lower trailing earnings multiple (15.36 vs 19.17 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (40.61% vs 27.71% net margin).
•INCY grew revenue faster over the past five years (16.43% vs 16.05% CAGR).

Metrics side by side

Valuation

Metric	INCY	UTHR
P/E ratio	15.36	19.17
Forward P/E	25.10	18.61
P/S ratio	4.31	7.72
P/B ratio	3.96	4.15
PEG ratio	0.73	1.16
EV / EBITDA	10.94	15.34
FCF yield	7.65%	4.15%

Profitability

Metric	INCY	UTHR
Gross margin	92.62%	86.58%
Operating margin	31.57%	45.34%
Net margin	27.71%	40.61%
ROE	25.41%	21.82%
ROIC	20.58%	16.13%

Growth (annualized)

Metric	INCY	UTHR
Revenue CAGR (5Y)	16.43%	16.05%
EPS CAGR (5Y)	21.19%	20.93%
FCF CAGR (5Y)	33.69%	12.12%
Total return CAGR (5Y)	9.29%	20.28%

Frequently asked

Which has the lower trailing P/E, INCY or UTHR?: INCY has the lower trailing P/E: INCY trades at 15.36 and UTHR at 19.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, INCY or UTHR?: Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus UTHR at 16.05%.
Is INCY or UTHR more profitable?: UTHR runs the higher net margin — INCY at 27.71% versus UTHR at 40.61%.
How have INCY and UTHR total returns compared?: Over the past 10 years, INCY delivered 2.96% and UTHR delivered 15.25% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio United Therapeutics P/E ratio Incyte dividend yield United Therapeutics dividend yield Incyte ROE United Therapeutics ROE Incyte operating margin United Therapeutics operating margin Incyte revenue growth United Therapeutics revenue growth Incyte free cash flow United Therapeutics free cash flow

Incyte & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 5, 2026.